Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 5
2003 7
2004 7
2005 15
2006 9
2007 18
2008 18
2009 17
2010 12
2011 16
2012 12
2013 9
2014 10
2015 15
2016 19
2017 10
2018 6
2019 11
2020 5
2021 8
2022 3
2023 3
2024 3
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

218 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Analgesic Efficacy of Etoricoxib following Third Molar Surgery: A Meta-analysis.
la Torre LF, Franco-González DL, Brennan-Bourdon LM, Molina-Frechero N, Alonso-Castro ÁJ, Isiordia-Espinoza MA. la Torre LF, et al. Behav Neurol. 2021 Sep 8;2021:9536054. doi: 10.1155/2021/9536054. eCollection 2021. Behav Neurol. 2021. PMID: 34539935 Free PMC article. Review.
A similar analgesic efficacy between etoricoxib and nonselective Cox-2 NSAIDs was informed in 3/8 studies (2 compared to ibuprofen and 1 to naproxen sodium). Moreover, the number of patients requiring rescue analgesics in the postoperative period showed a statistical diffe …
A similar analgesic efficacy between etoricoxib and nonselective Cox-2 NSAIDs was informed in 3/8 studies (2 compared to ibuprofen an …
The Influence of Etoricoxib on Pain Control for Laparoscopic Cholecystectomy: A Meta-analysis of Randomized Controlled Trials.
Qiu J, Xie M, Qu R. Qiu J, et al. Surg Laparosc Endosc Percutan Tech. 2019 Jun;29(3):150-154. doi: 10.1097/SLE.0000000000000635. Surg Laparosc Endosc Percutan Tech. 2019. PMID: 30855399
INTRODUCTION: The efficacy of etoricoxib on pain control for laparoscopic cholecystectomy remains controversial. We conduct a systematic review and meta-analysis to explore the impact of etoricoxib on pain intensity after laparoscopic cholecystectomy. ...CONCLUSIONS …
INTRODUCTION: The efficacy of etoricoxib on pain control for laparoscopic cholecystectomy remains controversial. We conduct a systema …
Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis.
da Costa BR, Pereira TV, Saadat P, Rudnicki M, Iskander SM, Bodmer NS, Bobos P, Gao L, Kiyomoto HD, Montezuma T, Almeida MO, Cheng PS, Hincapié CA, Hari R, Sutton AJ, Tugwell P, Hawker GA, Jüni P. da Costa BR, et al. BMJ. 2021 Oct 12;375:n2321. doi: 10.1136/bmj.n2321. BMJ. 2021. PMID: 34642179 Free PMC article.
Five oral preparations (diclofenac 150 mg/day, etoricoxib 60 and 90 mg/day, and rofecoxib 25 and 50 mg/day) had 99% probability of more pronounced treatment effects than the minimal clinically relevant reduction in pain. ...Oxymorphone 80 mg/day had the highest risk of dro …
Five oral preparations (diclofenac 150 mg/day, etoricoxib 60 and 90 mg/day, and rofecoxib 25 and 50 mg/day) had 99% probability of mo …
Single dose oral etoricoxib for acute postoperative pain in adults.
Clarke R, Derry S, Moore RA. Clarke R, et al. Cochrane Database Syst Rev. 2014 May 8;2014(5):CD004309. doi: 10.1002/14651858.CD004309.pub4. Cochrane Database Syst Rev. 2014. PMID: 24809657 Free PMC article. Review.
Sixty-six per cent of participants with etoricoxib 120 mg and 12% with placebo reported at least 50% pain relief (NNT 1.8 (1.7 to 2.0); high-quality evidence). ...Other doses (60, 180, and 240 mg) were each studied in only one treatment arm.Significantly fewer participants …
Sixty-six per cent of participants with etoricoxib 120 mg and 12% with placebo reported at least 50% pain relief (NNT 1.8 (1.7 to 2.0 …
Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis.
Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, Egger M, Jüni P. Trelle S, et al. BMJ. 2011 Jan 11;342:c7086. doi: 10.1136/bmj.c7086. BMJ. 2011. PMID: 21224324 Free PMC article. Review.
Patients were allocated to naproxen, ibuprofen, diclofenac, celecoxib, etoricoxib, rofecoxib, lumiracoxib, or placebo. Compared with placebo, rofecoxib was associated with the highest risk of myocardial infarction (rate ratio 2.12, 95% credibility interval 1.26 to 3.56), f …
Patients were allocated to naproxen, ibuprofen, diclofenac, celecoxib, etoricoxib, rofecoxib, lumiracoxib, or placebo. Compared with …
Nonsteroidal anti-inflammatory drugs for dysmenorrhoea.
Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M. Marjoribanks J, et al. Cochrane Database Syst Rev. 2015 Jul 30;2015(7):CD001751. doi: 10.1002/14651858.CD001751.pub3. Cochrane Database Syst Rev. 2015. PMID: 26224322 Free PMC article.
Non-selective NSAIDs versus COX-2-specific selectorsOnly two of the included studies utilised COX-2-specific inhibitors (etoricoxib and celecoxib). There was no evidence that COX-2-specific inhibitors were more effective or tolerable for the treatment of dysmenorrhoea than …
Non-selective NSAIDs versus COX-2-specific selectorsOnly two of the included studies utilised COX-2-specific inhibitors (etoricoxib a …
Efficacy and safety of etoricoxib compared with NSAIDs in acute gout: a systematic review and a meta-analysis.
Zhang S, Zhang Y, Liu P, Zhang W, Ma JL, Wang J. Zhang S, et al. Clin Rheumatol. 2016 Jan;35(1):151-8. doi: 10.1007/s10067-015-2991-1. Epub 2015 Jun 24. Clin Rheumatol. 2016. PMID: 26099603
Six trials including 851 patients were identified. Both etoricoxib and NSAIDs had an effect on inflammation and analgesia. Compared with indometacin and diclofenac, etoricoxib had a lower incidence of adverse events. ...Etoricoxib is tolerated better by patie …
Six trials including 851 patients were identified. Both etoricoxib and NSAIDs had an effect on inflammation and analgesia. Compared w …
Single dose oral etoricoxib for acute postoperative pain in adults.
Clarke R, Derry S, Moore RA, McQuay HJ. Clarke R, et al. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004309. doi: 10.1002/14651858.CD004309.pub2. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2012 Apr 18;(4):CD004309. doi: 10.1002/14651858.CD004309.pub3. PMID: 19370600 Updated.
BACKGROUND: Etoricoxib is a selective cyclo-oxygenase-2 (COX-2) inhibitor prescribed for the relief of chronic pain in osteoarthritis and rheumatoid arthritis, and acute pain. ...At least 50% pain relief was reported by 79% with etoricoxib 120 mg and 12% with placeb …
BACKGROUND: Etoricoxib is a selective cyclo-oxygenase-2 (COX-2) inhibitor prescribed for the relief of chronic pain in osteoarthritis …
The Efficacy of Oral Etoricoxib in Pain Control During Colposcopy-Directed Cervical Biopsy: A Randomized Control Trial.
Sivapornpan S, Punyashthira A, Chantawong N, Wisarnsirirak P, Mairaing K, Thaweekul Y, Poomtavorn Y, Pattaraarchachai J, Suwannarurk K. Sivapornpan S, et al. Asian Pac J Cancer Prev. 2023 Aug 1;24(8):2855-2859. doi: 10.31557/APJCP.2023.24.8.2855. Asian Pac J Cancer Prev. 2023. PMID: 37642074 Free PMC article. Clinical Trial.
OBJECTIVE: To investigate the effectiveness and safety of oral etoricoxib administration before colposcopic procedure for pain relief during and after colposcopy. ...They were allocated into two groups: etoricoxib group and control group. Thirty minutes prior to col …
OBJECTIVE: To investigate the effectiveness and safety of oral etoricoxib administration before colposcopic procedure for pain relief …
The Cyclooxygenase 2 Inhibitor Etoricoxib as Adjunctive Therapy in Tuberculosis Impairs Macrophage Control of Mycobacterial Growth.
Nore KG, Louet C, Bugge M, Gidon A, Jørgensen MJ, Jenum S, Dyrhol-Riise AM, Tonby K, Flo TH. Nore KG, et al. J Infect Dis. 2024 Mar 14;229(3):888-897. doi: 10.1093/infdis/jiad390. J Infect Dis. 2024. PMID: 37721470 Free PMC article. Clinical Trial.
We investigated the antimycobacterial capacity of macrophages from patients with tuberculosis in a phase 1/2 randomized clinical trial (TBCOX2) of the cyclooxygenase-2 inhibitor etoricoxib. METHODS: Peripheral blood mononuclear cells from 15 patients with tuberculosis trea …
We investigated the antimycobacterial capacity of macrophages from patients with tuberculosis in a phase 1/2 randomized clinical trial (TBCO …
218 results